Assessing new technologies for cervical cancer screening: Beyond sensitivity

Journal of Lower Genital Tract Disease

Volumn 12, Issue 4, 2008, Pages 311-315

  Massad, L Stewart ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cervical cancer screening; Human papillomavirus testing; Papanocolaou test; Sensitivity; Specificity

Indexed keywords

ARTICLE; CANCER SCREENING; DIAGNOSTIC ACCURACY; FOLLOW UP; PAPANICOLAOU TEST; PREMATURE LABOR; PREVALENCE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VERRUCA VULGARIS; WART VIRUS;

ADULT; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 55149120453     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/LGT.0b013e31817d750c     Document Type: Article

References (19)

1. Warner EE, Mulshine JL. Lung cancer screening with spiral CT: toward a working strategy. Oncology (Williston Park) 2004;18:564-75.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
3. Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D, for the 2006 ASCCP-sponsored consensus conference. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007;197:346-55.
4. Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkiinson EJ, Solomon D, for the 2006 ASCCP-sponsored consensus conference. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in-situ. Am J Obstet Gynecol 2007;197: 340-5.
5. Grimes DA, Schulz KF. Uses and abuses of screening tests. Lancet 2002;359:881-4.
6. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, et al. Accuracy of the Papanicolaou test in screening for an follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000; 132:810-9.
7. Ronco G, Cuzick J, Pierotti P, Cariaggi MP, Dalla Palma P, Naldoni C, et al, the New Technologies for Cervical Cancer Screening Working Group. Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial. BMJ 2007;335:28-34.
8. Eddy D. Screening for cervical cancer. Ann Intern Med 1990;113:214-26.
9. Spence AR, Goggin P, Franco EL. Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev Med 2007;45:93-106.
10. Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 2002;288:1749-57.
11. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection among females in the United States. JAMA 2007;297:813-9.
12. Benard VB, Coughlin SS, Thompson T, Richardson LC. Cervical cancer incidence in the United states by area of residence, 1998-2001. Obstet Gynecol 2007;110:681-6.
13. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993;12: 186-92.
14. Castle PE, Wacholder S, Lorincz AT, Scott DR, Sherman ME, Glass AG, et al. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst 2002;94:1406-14.
15. Munoz N, Castellsague X, Berrington de Gonzalez A, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006;24S3:1-10.
16. Sadler L, Saftlas A, Wang W, Exeter M, Whittaker J, McCowan L. Treatment for cervical intraepithelial neoplasia and risk of preterm delivery. JAMA 2004;291:2100-6.
17. Jakobsson M, Gissler M, Sainio S, Paavonen J, Tapper AM. Preterm delivery after surgical treatment for cervical intraepithelial neoplasia. Obstet Gynecol 2007;109:309-13.
18. Sharpe PA, Brandt HM, McCree DH. Knowledge and beliefs about abnormal pap test results and HPV among women with high-risk HPV: results from in-depth interviews. Women Health 2005;42:107-33.
19. Myers ER, McCrory DC, Subramanian S, McCall N, Nanda K, Datta S, et al. Setting the target for a better cervical screening test: characteristics of a cost-effective test for cervical neoplasia screening. Obstet Gynecol 2000;96: 645-52.